ProPharma Announces Changes to Its Executive Leadership Team
Nyenta.com/10275210

Trending...
RALEIGH, N.C., April 11, 2024 ~ ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, has recently announced changes to its executive leadership team. The company, which is a portfolio company of Odyssey Investment Partners, has welcomed Kirk Wroblewski as its new Chief Information Officer (CIO) and Andrew Shaw as General Counsel. In addition, Zosya Popik has been promoted to the role of Chief Marketing Officer (CMO).

According to Mike Stomberg, Chief Executive Officer of ProPharma, these changes are aimed at propelling the company's global growth. "We are thrilled to welcome Kirk and Andrew to the executive team and to elevate Zosya as our new Chief Marketing Officer," said Stomberg. "The combined expertise of each of these team members positions ProPharma to transcend in the industry and continue to compete on a global scale."

Wroblewski brings over 20 years of experience in healthcare data and analytics to his new role as CIO. He most recently served as the Chief Data Officer for Healthfirst where he helped develop technical roadmaps that aligned with business goals in the healthcare sector. With previous leadership roles at Rainfall Health, Deloitte Digital, Merz Pharma, LabCorp and GSK, Wroblewski is a highly accomplished information executive with a focus on finding solutions.

More on Nyenta.com
"I am excited to join ProPharma's executive team," said Wroblewski. "The company is an industry leader in helping companies advance at every stage of the pharmaceutical lifecycle. As the new CIO, I am ready to use my expertise in data and analytics to ensure that ProPharma's IT department delivers outcomes that support the business's mission."

Popik brings over 16 years of diverse marketing experience across Fortune 300 companies, fast-moving startups, and the consumer packaged goods (CPG) and life sciences industries. She recently led ProPharma's rebranding and repositioning initiative and has held leadership roles at Fortune 300 companies where she built and scaled digital marketing teams. Popik also spearheaded social media and digital efforts for Icon plc (formerly PRA Health Sciences). In her new role as CMO, she will continue to oversee strategic performance marketing, branding, marketing tech stack, and global communications.

"I am honored to lead ProPharma's marketing efforts during such a pivotal time for the company," said Popik. "With my experience in digital transformation, global branding, and digital growth, I am eager to contribute to ProPharma's role as the world's largest research consulting organization (RCO)."

More on Nyenta.com
As General Counsel of ProPharma, Shaw will oversee the company's global legal function. He brings over 20 years of experience in the life sciences industry from both private practice and in-house counsel roles. Prior to joining ProPharma, Shaw led the global legal team at Perspectum Ltd, a UK-based medical device company. He also held senior leadership positions within the legal departments at Fortrea and Syneos Health. Before that, he spent eight years in private practice specializing in complex commercial contracting, private equity M&A, and public company transactions.

"It is an honor to join a company that is dedicated to advancing global health through pioneering research and development," said Shaw. "I look forward to providing legal and operational excellence to support ProPharma as it continues to deliver impactful healthcare solutions and innovations to the industry."

With these changes in its executive leadership team, ProPharma is well-positioned for continued success in the life sciences industry on a global scale.
Filed Under: Business
Show All News | Report Violation

0 Comments

Latest on Nyenta.com